Dual-isotope 111In/ 177Lu SPECT imaging as a tool in molecular imaging tracer design

Contrast Media and Molecular Imaging

Volumn 7, Issue 2, 2012, Pages 214-222

  Hijnen, Nicole M ^a   de Vries, Anke ^a   Nicolay, Klaas ^a   Grüll, Holger ^a,b  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

Author keywords

CRAD; CRGD; Crosstalk; Dual isotope SPECT; Molecular imaging; Targeting; Tracer design

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; INDIUM 111; LUTETIUM 177; TETRAXETAN; DIAGNOSTIC AGENT; INDIUM; LUTETIUM; TRACER;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BONE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG UPTAKE; HEART; KIDNEY; LIGAND BINDING; LIVER; MOLECULAR IMAGING; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION STUDY; ANIMAL; COMPUTER ASSISTED TOMOGRAPHY; IMAGE QUALITY; METHODOLOGY; NEOPLASM; RADIOGRAPHY; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; INDIUM RADIOISOTOPES; LUTETIUM; MICE; MOLECULAR IMAGING; NEOPLASMS; PHANTOMS, IMAGING; RADIOACTIVE TRACERS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858721199     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.485     Document Type: Article

References (36)

1. Weissleder R RB, Rehemtulla A, Gambhir SS. Molecular Imaging Principles and Practice. People's Medical Publishing House-USA: Shelton, 2010.
2. Blankenberg FG. Molecular imaging: The latest generation of contrast agents and tissue characterization techniques. J Cell Biochem 2003; 90(3): 443-453.
3. Berman DS, Kang X, Tamarappoo B, Wolak A, Hayes SW, Nakazato R, Thomson LE, Kite F, Cohen I, Slomka PJ, Einstein AJ, Friedman JD. Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging. JACC Cardiovasc Imag 2009; 2(3): 273-282.
4. Hsieh PC, Lee IH, Yeh TL, Chen KC, Huang HC, Chen PS, Yang YK, Yao WJ, Lu RB, Chiu NT. Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study. Psychiat Res 2010; 184(3): 157-161.
5. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med 2010; 40(1): 3-15.
6. Heiba SI, Kolker D, Mocherla B, Kapoor K, Jiang M, Son H, Rangaswamy B, Kostakoglu L, Savitch I, DaCosta M, Machac J. The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol. J Foot Ankle Surg 2010; 49(6): 529-536.
7. Melis M, de Swart J, de Visser M, Berndsen SC, Koelewijn S, Valkema R, Boerman OC, Krenning EP, de Jong M. Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy. J Nucl Med 2010; 51(12): 1962-1968.
8. van Duijnhoven SM, Robillard MS, Nicolay K, Grull H. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. J Nucl Med; 52(2): 279-286.
9. Du Y, Frey EC. Quantitative evaluation of simultaneous reconstruction with model-based crosstalk compensation for 99mTc/123I dual-isotope simultaneous acquisition brain SPECT. Med Phys 2009; 36(6): 2021-2033.
10. Kao PF, Wey SP, Yang AS. Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging. Kaohsiung J Med Sci 2009; 25(11): 601-607.
11. Sanchez-Crespo A, Petersson J, Nyren S, Mure M, Glenny RW, Thorell JO, Jacobsson H, Lindahl SG, Larsson SA. A novel quantitative dual-isotope method for simultaneous ventilation and perfusion lung SPET. Eur J Nucl Med Mol Imag 2002; 29(7): 863-875.
12. Kadrmas DJ, Frey EC, Tsui BM. Simultaneous technetium-99m/thallium-201 SPECT imaging with model-based compensation for cross-contaminating effects. Phys Med Biol 1999; 44(7): 1843-1860.
13. Heo J, Wolmer I, Kegel J, Iskandrian AS. Sequential dual-isotope SPECT imaging with thallium-201 and technetium-99m-sestamibi. J Nucl Med 1994; 35(4): 549-553.
14. Ceccarelli C, Bianchi F, Trippi D, Brozzi F, Di Martino F, Santini P, Elisei R, Pinchera A. Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan. J Endocrinol Invest 2004; 27(9): 866-869.
15. Zhu X, Park MA, Gerbaudo VH, Moore SC. Quantitative simultaneous In-111/Tc-99m planar imaging in a long-bone infection phantom. Phys Med Biol 2007; 52(24): 7353-7365.
16. Port M, Idee JM, Medina C, Robic C, Sabatou M, Corot C. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals 2008; 21(4): 469-490.
17. Haubner R, Wester HJ, Reuning U, Senekowitsch-Schmidtke R, Diefenbach B, Kessler H, Stocklin G, Schwaiger M. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 1999; 40(6): 1061-1071.
18. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008; 8(8): 604-617.
19. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264(5158): 569-571.
20. Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 2001; 42(2): 326-336.
21. Janssen M, Frielink C, Dijkgraaf I, Oyen W, Edwards DS, Liu S, Rajopadhye M, Massuger L, Corstens F, Boerman O. Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation. Cancer Biother Radiopharm 2004; 19(4): 399-404.
22. Beer AJ, Niemeyer M, Carlsen J, Sarbia M, Nahrig J, Watzlowik P, Wester HJ, Harbeck N, Schwaiger M. Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J Nucl Med 2008; 49(2): 255-259.
23. Ferl GZ, Dumont RA, Hildebrandt IJ, Armijo A, Haubner R, Reischl G, Su H, Weber WA, Huang SC. Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice. J Nucl Med 2009; 50(2): 250-258.
24. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 2009; 16(6): 510-520.
25. Kok RJ, Schraa AJ, Bos EJ, Moorlag HE, Asgeirsdottir SA, Everts M, Meijer DK, Molema G. Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics. Bioconjug Chem 2002; 13(1): 128-135.
26. Mulder WJ, Strijkers GJ, Habets JW, Bleeker EJ, van der Schaft DW, Storm G, Koning GA, Griffioen AW, Nicolay K. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005; 19(14): 2008-2010.
27. Boyd M, Sorensen A, McCluskey AG, Mairs RJ. Radiation quality-dependent bystander effects elicited by targeted radionuclides. J Pharm Pharmacol 2008; 60(8): 951-958.
28. Proffitt RT, Williams LE, Presant CA, Tin GW, Uliana JA, Gamble RC, Baldeschwieler JD. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice. J Nucl Med 1983; 24(1): 45-51.
29. Breeman WA, van der Wansem K, Bernard BF, van Gameren A, Erion JL, Visser TJ, Krenning EP, de Jong M. The addition of DTPA to [177Lu-DOTA0, Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity. Eur J Nucl Med Mol Imag 2003; 30(2): 312-315.
30. Dijkgraaf I, Kruijtzer JA, Frielink C, Corstens FH, Oyen WJ, Liskamp RM, Boerman OC. Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide. Int J Cancer 2007; 120(3): 605-610.
31. Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imag 2007; 34(7): 982-993.
32. Schramm NU, Lackas C, Forrer F, de Jong M, Hoppin JW, Van Cauter SC, Haemisch Y. The NanoSPECT/CT: a high-sensitivity small-animal SPECT/CT with sub-millimeter spatial resolution. Available from:.
33. Schramm NU, Hoppin JW, Lackas C, Gershman B, Norenberg JP, de Jong M. The NanoSPECT/CT: a high-performance SPECT/CT for small-animal research. Available from:.
34. Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, Chen X. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med 2006; 47(1): 113-121.
35. NIH. Guide for the Use and Care of Laboratory Animals, Vol. 86. National Academy Press: Washington, DC; 1985.
36. Zielhuis GA. Handleiding medisch-wetenschappelijk onderzoek. Elsevier Gezondheidszorg: Maarssen, 2000; 87-98.